{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T16:07:58Z","timestamp":1784045278343,"version":"3.55.0"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>In chronic heart failure (HF), decongestion is hindered by reduced renal function and diuretic resistance. This study compared the effect of eGFR and serum bicarbonate on three diuretic regimens in congestion-refractory HF patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>This is a prespecified post-hoc analysis of DEA-HF, a randomized, crossover trial (n = 42). Patients received, in random order, weekly treatments of IV furosemide 250 mg; oral metolazone 5mg + IV furosemide 250 mg; and IV acetazolamide 500mg + IV furosemide 250 mg. Primary endpoint: 6h-Natriuresis; secondary: 6h-diuresis and decongestion measures at 7 \u00b1 3 days. Mixed models assessed effect modification by eGFR (\u226430 vs. &amp;gt; 30 mL\/min\/1.73m2) and by serum bicarbonate (\u2264vs.&amp;gt; median-29.6 mmol\/L). Higher eGFR was associated with greater natriuresis and diuresis (4735 mg vs. 3211 mg, P = 0.0004; 1.93L vs. 1.49L, P = 0.0078). In patients with eGFR &amp;gt; 30, addition of metolazone to furosemide led to higher natriuresis compared to acetazolamide addition (5525 mg vs. 4379 mg, P = 0.04) or to furosemide monotherapy (5525 mg vs. 4303 mg, P = 0.014); no regimen differences were observed at eGFR \u2264 30. Independently, higher serum bicarbonate predicted greater natriuresis and diuresis (4858 mg vs. 3576 mg, P = 0.0008; 1.99 vs. 1.56L, P = 0.0014). There was no difference in clinical decongestion measures. All regimens were well-tolerated with comparable safety concerns regarding renal function, electrolyte disturbances, or hypotension.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In ambulatory patients with congestion-refractory HF and eGFR &amp;gt; 30 mL\/min\/1.73m2, natriuretic and diuretic responses are augmented across all regimens, with metolazone providing additional improvement in natriuresis. When eGFR \u2264 30 mL\/min\/1.73m2, neither metolazone nor acetazolamide provides additional benefit. High serum bicarbonate predicts better natriuretic and diuretic response, as well as additional benefit from metolazone treatment. High-dose diuretics had comparable safety profiles across the eGFR spectrum.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ehjcvp\/pvag019","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:03:46Z","timestamp":1778760226000},"page":"309-319","source":"Crossref","is-referenced-by-count":0,"title":["Kidney function and acid\u2013base status as gatekeepers of natriuretic and diuretic responsiveness in chronic HF: insights from the DEA-HF clinical trial"],"prefix":"10.1093","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-8114-9223","authenticated-orcid":false,"given":"Ina","family":"Volis","sequence":"first","affiliation":[{"name":"The Heart Failure Unit, Department of Cardiology, Rambam Health Care Campus, Haifa 3109601 ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6366-3093","authenticated-orcid":false,"given":"Amit","family":"Gruber","sequence":"additional","affiliation":[{"name":"The Heart Failure Unit, Department of Cardiology, Rambam Health Care Campus, Haifa 3109601 ,","place":["Israel"]},{"name":"Ruth and Bruce Rappaport Faculty of Medicine, Technion The , Haifa 3525433 ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9492-8704","authenticated-orcid":false,"given":"Aharon (Ronnie)","family":"Abbo","sequence":"additional","affiliation":[{"name":"The Heart Failure Unit, Department of Cardiology, Rambam Health Care Campus, Haifa 3109601 ,","place":["Israel"]},{"name":"Ruth and Bruce Rappaport Faculty of Medicine, Technion The , Haifa 3525433 ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doron","family":"Aronson","sequence":"additional","affiliation":[{"name":"The Heart Failure Unit, Department of Cardiology, Rambam Health Care Campus, Haifa 3109601 ,","place":["Israel"]},{"name":"Ruth and Bruce Rappaport Faculty of Medicine, Technion The , Haifa 3525433 ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Girerd","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Lorraine, INSERM, Centre d'Investigations Cliniques-Plurith\u00e9matique 1433, CHRU Nancy, and INSERM U1116, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists) , Nancy 54000 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren Lund","family":"Kristensen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Copenhagen University Hospital\u2014Rigshospitalet , Copenhagen 2100 ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Zukermann","sequence":"additional","affiliation":[{"name":"The Heart Failure Unit, Department of Cardiology, Rambam Health Care Campus, Haifa 3109601 ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Alberkant","sequence":"additional","affiliation":[{"name":"The Heart Failure Unit, Department of Cardiology, Rambam Health Care Campus, Haifa 3109601 ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Sitnitsky","sequence":"additional","affiliation":[{"name":"The Heart Failure Unit, Department of Cardiology, Rambam Health Care Campus, Haifa 3109601 ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Kruger","sequence":"additional","affiliation":[{"name":"The Heart Failure Unit, Department of Cardiology, Rambam Health Care Campus, Haifa 3109601 ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polina","family":"Khasis","sequence":"additional","affiliation":[{"name":"The Heart Failure Unit, Department of Cardiology, Rambam Health Care Campus, Haifa 3109601 ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeny","family":"Bravo","sequence":"additional","affiliation":[{"name":"The Heart Failure Unit, Department of Cardiology, Rambam Health Care Campus, Haifa 3109601 ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boaz","family":"Elad","sequence":"additional","affiliation":[{"name":"The Heart Failure Unit, Department of Cardiology, Rambam Health Care Campus, Haifa 3109601 ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludmila","family":"Helmer Levin","sequence":"additional","affiliation":[{"name":"The Heart Failure Unit, Department of Cardiology, Rambam Health Care Campus, Haifa 3109601 ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2464-7357","authenticated-orcid":false,"given":"Oren","family":"Caspi","sequence":"additional","affiliation":[{"name":"The Heart Failure Unit, Department of Cardiology, Rambam Health Care Campus, Haifa 3109601 ,","place":["Israel"]},{"name":"Ruth and Bruce Rappaport Faculty of Medicine, Technion The , Haifa 3525433 ,","place":["Israel"]},{"name":"Clinical Research Institute at Rambam (CRIR) , Haifa 3109601 ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"2026071411420743700_pvag019-B1","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/J.JCHF.2024.04.014","article-title":"Diuresis efficacy in ambulatory congested heart failure patients: intrapatient comparison of 3 Diuretic Regimens (DEA-HF)","volume":"12","author":"Abbo","year":"2024","journal-title":"JACC Heart Fail"},{"key":"2026071411420743700_pvag019-B2","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2026071411420743700_pvag019-B3","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1002\/ehf2.15358","article-title":"Efficacy of ambulatory intravenous diuresis for chronic heart failure patients: insights from the DEA-HF trial","volume":"12","author":"Gruber","year":"2025","journal-title":"ESC Heart Fail"},{"key":"2026071411420743700_pvag019-B4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/J.REC.2023.05.003","article-title":"Prevalence and clinical profile of kidney disease in patients with chronic heart failure. Insights from the Spanish cardiorenal registry","volume":"77","author":"Cobo Marcos","year":"2024","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"2026071411420743700_pvag019-B5","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1002\/EJHF.821","article-title":"Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction","volume":"19","author":"L\u00f6fman","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026071411420743700_pvag019-B6","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1053\/j.ajkd.2021.08.003","article-title":"A unifying approach for GFR estimation: recommendations of the NKF-ASN task force on reassessing the inclusion of race in diagnosing kidney disease","volume":"79","author":"Delgado","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"2026071411420743700_pvag019-B7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/EJHF.1369","article-title":"The use of diuretics in heart failure with congestion\u2014a position statement from the Heart Failure Association of the European Society of Cardiology","volume":"21","author":"Mullens","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2026071411420743700_pvag019-B8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/J.JCHF.2024.09.017","article-title":"Diuretic potentiation strategies in acute heart failure","volume":"13","author":"Siddiqi","year":"2025","journal-title":"JACC Heart Fail"},{"key":"2026071411420743700_pvag019-B9","doi-asserted-by":"publisher","first-page":"e44624","DOI":"10.7759\/CUREUS.44624","article-title":"Combination diuretic therapy with thiazides: a systematic review on the beneficial approach to overcome refractory fluid overload in heart failure","volume":"15","author":"Gogikar","year":"2023","journal-title":"Cureus"},{"key":"2026071411420743700_pvag019-B10","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/J.JCHF.2019.09.012","article-title":"Diuretic strategies for loop diuretic resistance in acute heart failure: the 3T trial","volume":"8","author":"Cox","year":"2020","journal-title":"JACC Heart Fail"},{"key":"2026071411420743700_pvag019-B11","doi-asserted-by":"publisher","first-page":"e0137163","DOI":"10.1371\/JOURNAL.PONE.0137163","article-title":"Effect of Acetazolamide on obesity-induced glomerular hyperfiltration: a Randomized Controlled Trial","volume":"10","author":"Zingerman","year":"2015","journal-title":"PLoS One"},{"key":"2026071411420743700_pvag019-B12","doi-asserted-by":"publisher","first-page":"3672","DOI":"10.1093\/EURHEARTJ\/EHAD557","article-title":"Renal function and decongestion with Acetazolamide in acute decompensated heart failure: the ADVOR trial","volume":"44","author":"Meekers","year":"2023","journal-title":"Eur Heart J"},{"key":"2026071411420743700_pvag019-B13","doi-asserted-by":"publisher","first-page":"F958","DOI":"10.1152\/AJPRENAL.00476.2015","article-title":"Everything we always wanted to know about furosemide but were afraid to ask","volume":"310","author":"Huang","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"2026071411420743700_pvag019-B14","doi-asserted-by":"publisher","first-page":"e72118","DOI":"10.7759\/CUREUS.72118","article-title":"Assessing the effectiveness and safety of combination diuretic therapy in heart failure: a systematic review and meta-analysis","volume":"16","author":"Ayoti","year":"2024","journal-title":"Cureus"},{"key":"2026071411420743700_pvag019-B15","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1002\/PHAR.1798","article-title":"Efficacy and safety of intravenous chlorothiazide versus oral metolazone in patients with acute decompensated heart failure and loop diuretic resistance","volume":"36","author":"Shulenberger","year":"2016","journal-title":"Pharmacotherapy"},{"key":"2026071411420743700_pvag019-B16","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1681\/ASN.0000000515","article-title":"Acetazolamide therapy and kidney function in persons with non-albuminuric diabetes Mellitus Type 1","volume":"36","author":"Ginsberg","year":"2025","journal-title":"J Am Soc Nephrol"},{"key":"2026071411420743700_pvag019-B17","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1056\/NEJMoa2203094","article-title":"Acetazolamide in acute decompensated heart failure with volume overload","volume":"387","author":"Mullens","year":"2022","journal-title":"N Engl J Med"},{"key":"2026071411420743700_pvag019-B18","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/J.JACC.2019.12.059","article-title":"Diuretic therapy for patients with heart failure: JACC State-of-the-Art Review","volume":"75","author":"Felker","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026071411420743700_pvag019-B19","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1002\/EJHF.2988","article-title":"Combining loop and thiazide diuretics for acute heart failure across the estimated glomerular filtration rate spectrum: a -hoc analysis of the CLOROTIC trial","volume":"25","author":"Trull\u00e0s","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"2026071411420743700_pvag019-B20","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1093\/eurheartj\/ehad236","article-title":"Pre-treatment bicarbonate levels and decongestion by Acetazolamide: the ADVOR trial","volume":"44","author":"Martens","year":"2023","journal-title":"Eur Heart J"},{"key":"2026071411420743700_pvag019-B21","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/J.JASH.2012.07.004","article-title":"Thiazide diuretics in advanced chronic kidney disease","volume":"6","author":"Agarwal","year":"2012","journal-title":"J Am Soc Hypertens"},{"key":"2026071411420743700_pvag019-B22","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/J.CARDFAIL.2015.07.006","article-title":"Diuretic response: clinical and hemodynamic predictors and relation to clinical outcome","volume":"22","author":"Aronson","year":"2016","journal-title":"J Card Fail"},{"key":"2026071411420743700_pvag019-B23","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/EJHF.2384","article-title":"Worsening renal function in acute heart failure in the context of diuretic response","volume":"24","author":"Emmens","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2026071411420743700_pvag019-B24","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/EURHEARTJ\/EHT386","article-title":"Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis","volume":"35","author":"Damman","year":"2014","journal-title":"Eur Heart J"},{"key":"2026071411420743700_pvag019-B25","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nrcardio.2014.215","article-title":"Diuretic response in acute heart failure\u2014pathophysiology, evaluation, and therapy","volume":"12","author":"Ter Maaten","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"2026071411420743700_pvag019-B26","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.jacc.2010.06.034","article-title":"Combination of loop diuretics with thiazide-type diuretics in heart failure","volume":"56","author":"Jentzer","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026071411420743700_pvag019-B27","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1056\/NEJMOA1005419","article-title":"Diuretic strategies in patients with acute decompensated heart failure","volume":"364","author":"Felker","year":"2011","journal-title":"N Engl J Med"},{"key":"2026071411420743700_pvag019-B28","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/J.CARDFAIL.2016.06.423","article-title":"Relevance of changes in serum creatinine during a heart failure trial of decongestive strategies: insights from the DOSE trial","volume":"22","author":"Brisco","year":"2016","journal-title":"J Card Fail"},{"key":"2026071411420743700_pvag019-B29","doi-asserted-by":"publisher","first-page":"4420","DOI":"10.1002\/EHF2.14900","article-title":"Elevated blood bicarbonate levels and long-term adverse outcomes in patients with chronic heart failure","volume":"11","author":"Misaka","year":"2024","journal-title":"ESC Heart Fail"},{"key":"2026071411420743700_pvag019-B30","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1681\/ASN.2006060620","article-title":"Acid-base transport by the renal proximal tubule","volume":"17","author":"Boron","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"2026071411420743700_pvag019-B31","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1161\/HYPERTENSIONAHA.120.15205","article-title":"Pathophysiology of diuretic resistance and its implications for the management of chronic heart failure","volume":"76","author":"Wilcox","year":"2020","journal-title":"Hypertension"}],"container-title":["European Heart Journal - Cardiovascular Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcvp\/advance-article-pdf\/doi\/10.1093\/ehjcvp\/pvag019\/68327472\/pvag019.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcvp\/article-pdf\/12\/4\/309\/68327472\/pvag019.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcvp\/article-pdf\/12\/4\/309\/68327472\/pvag019.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:42:11Z","timestamp":1784043731000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcvp\/article\/12\/4\/309\/8686334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":31,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,5,18]]},"published-print":{"date-parts":[[2026,7,14]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcvp\/pvag019","relation":{},"ISSN":["2055-6837","2055-6845"],"issn-type":[{"value":"2055-6837","type":"print"},{"value":"2055-6845","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,5,18]]}}}